Director, Marketing Sciences HIV PrEP at Gilead Sciences

Foster City, California, United States

Gilead Sciences Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

  • 12+ years of relevant experience with Bachelor’s Degree. MBA or other related graduate-level degree is a plus
  • 6+ years of work experience in forecasting, marketing sciences, market research, strategic consulting or other analytical work in the biotech/pharmaceutical industries in leadership roles with direct management experience
  • Track record of delivering actionable insights through successful execution of forecasting and marketing analytics projects, as well as strategic problem-solving skills
  • Exceptional ability to manage multiple projects in a fast-moving entrepreneurial environment, with changing priorities and significant time pressures
  • Strong communication skills (both verbal and written). Demonstrated ability to collaborate and work cross-functionally

Responsibilities

  • Conduct market research in US, EU, CAN and AUS markets to answer strategic questions and support in launch of HIV Prevention pipeline assets
  • Leverage primary and secondary research insights and team inputs to design and build accurate, actionable, and evidenced based forecasting models. Produce analogues, formulate assumptions, and define opportunities and risks associated with the forecast
  • Develop and maintain a dashboard for tracking performance of each product. Develop a mechanism for identifying variations in performance vs. target, and gathering relevant data to help evaluate and determine next steps. Synthesize market dynamics to identify potential drivers impacting performance to inform marketing and sales decisions
  • Define analytical priorities in collaboration with rest of the commercial organization. Ensure successful execution of secondary analytics projects and integrating results with primary market research and latest competitive intelligence into actionable insights
  • Drive analytics for planned and ad hoc strategic projects including scenario analysis to help drive key decisions for the business

Skills

Market Research
Marketing Analytics
HIV PrEP
Commercial Strategy
Stakeholder Management
Therapeutic Knowledge
Product Performance Analysis
Competitor Analysis

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI